Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 24, 2026
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.
Journal: Clinical pharmacokinetics
Published: February 05, 2026
PRMT1-mediated metabolic reprogramming promotes leukemogenesis.
Journal: eLife
Published: August 13, 2025
Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 12, 2025
Outcomes of Referrals in Pediatric Patients With Peripheral Lymphadenopathy.
Journal: Journal of pediatric hematology/oncology
Published: February 27, 2024
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 30, 2023
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms.
Journal: Pediatric blood & cancer
Published: July 06, 2023
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.
Journal: Blood advances
Published: December 05, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy.
Journal: Transplantation and cellular therapy
Published: June 08, 2022
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.
Journal: JAMA oncology
Published: November 11, 2021
Last Updated: 09/26/2026